国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

更新于 7月23日

Research Senior Associate

1.5-2萬
  • 上海浦東新區(qū)
  • 3-5年
  • 碩士
  • 全職
  • 招1人

職位描述

生物藥
POSITION DESCRIPTION:
Iasobio-shanghai innovation center is seeking a Research Senior Associate, Cell Therapy with the following duties:
?maintain primary immune cell cultures and produce human and mouse CAR T cells.
?Plan, prioritize, and execute CAR T cell production, applying leadership qualities to facilitate a seamless workflow for experiments.
?Establish new experimental designs for CAR T cells co-cultured with other target cell types using a range of techniques and analytical method such as flow cytometry, cytotoxicity readouts, and/or gene expression.
?Produce, titer, and bank viral vectors to express CAR and other constructs in T cells.
?Collaborate with project leaders to plan experiments, analyze and interpret data, and communicate findings internally.
?Prepare study protocols, reports, and documentation.
?Work with manager and teammates to troubleshoot complex problems in creative and effective ways.
?Actively participate in the innovation and optimization of cell therapy processes to ensure the delivery of project goals.
REQUIREMENTS:
Master's degree in biotechnology, immunology, cell biology or related field, plus 3 years of related experience. Prior experience must include:
?maintain primary cell cultures, process tissue samples into single cell suspensions, cryopreserve and recover cell lines and primary immune cells
?execute CAR-T generation and related function assays including viral vector or non- viral vector generation and titration
?perform flow cytometry-based experiments, including panel optimization, gating strategy, and data analysis, including flow cytometer instruments maintenance and troubleshooting, consulting to optimize instrument setup, and assisting users to operate the instruments
?optimize in-vitro assays for enhancing T cell killing and persistence.

工作地點

浦東新區(qū)上海馴鹿生物技術(shù)有限公司

職位發(fā)布者

張欣/人事經(jīng)理

昨日活躍
立即溝通
公司Logo南京馴鹿生物技術(shù)股份有限公司
南京馴鹿醫(yī)療技術(shù)有限公司由臨床團(tuán)隊、生物制藥科學(xué)家和投資人團(tuán)隊聯(lián)合創(chuàng)立,致力于腫瘤細(xì)胞免疫治療的藥物開發(fā)及技術(shù)服務(wù)。馴鹿醫(yī)療管理團(tuán)隊多數(shù)來源于生物制藥上市公司,具有生物制藥產(chǎn)業(yè)化背景和熟練的前端研發(fā)向臨床轉(zhuǎn)化能力。公司的國際化臨床專家團(tuán)隊擁有豐富的細(xì)胞治療產(chǎn)品研發(fā)和臨床應(yīng)用經(jīng)驗,為研發(fā)產(chǎn)品精準(zhǔn)定位及開發(fā)成功率提供有力的保障。公司位于南京生物醫(yī)藥谷,現(xiàn)有近5000平的科研及產(chǎn)業(yè)化基地。2017年11月,按照歐盟標(biāo)準(zhǔn)設(shè)計的質(zhì)粒、病毒及細(xì)胞制備GMP車間正式落成。馴鹿醫(yī)療以抗腫瘤新藥創(chuàng)新及創(chuàng)造生命的奇跡為己任,產(chǎn)品研發(fā)定位于擁有全球自有知識產(chǎn)權(quán)與具備國際化創(chuàng)新能力。公司的產(chǎn)品涵蓋抗體;CAR-T細(xì)胞治療血液腫瘤、部分實體瘤、病毒感染類腫瘤及通用型CAR-T;系列的細(xì)胞治療預(yù)前及預(yù)后檢測產(chǎn)品;細(xì)胞因子風(fēng)暴控制等。針對血液腫瘤的CAR-T產(chǎn)品通過在合作臨床機(jī)構(gòu)的臨床試驗驗證,治療效果與國際同步,并在細(xì)胞治療副作用控制及延緩復(fù)發(fā)上具有明顯優(yōu)勢。公司已完成由國內(nèi)生物制藥上市公司領(lǐng)投的c輪融資。公司管理團(tuán)隊有著豐富的規(guī)范管理及資本運營經(jīng)驗,公司計劃3年內(nèi)實現(xiàn)上市。公司獨特的合伙人制度及全員持股計劃呼喚有夢想的你加盟。馴鹿,擁有獨具一格的辦公環(huán)境、國際化的研發(fā)及生產(chǎn)平臺、有競爭力的薪酬制度,更是創(chuàng)造生命奇跡、具有夢想的舞臺。馴鹿尋你,一“鹿”同行。
公司主頁